真空辅助系统治疗乳腺良性肿瘤的临床实践

The clinical practice of vacuum assisted system in treating benign breast tumors

目的探讨真空辅助系统治疗乳腺良性肿瘤的安全性和临床疗效。方法选择2017年01月-2020年01月期间,在广州市增城区人民医院接受手术治疗的200例乳腺疾病患者,平均年龄(39.23±13.02)岁。根据手术方式的不同分为两组,其中麦默通手术组(115例)和开放手术组(85例),比较两组患者手术时间、疼痛、出血量、术后血肿/血清肿和感染;并追踪患者术后6月及1年随访情况。结果麦默通手术组的手术时间、出血量、恢复时间及术后血肿/血清肿和感染均低于开放手术组,差异均有统计学意义(P<0.05);绝大多数患者乳房美容效果满意,麦默通组的满意度(99.12%)高于开放组(84.34%,P<0.05);术后随访发现麦默通手术组复发率(4.39%)与开放手术组无统计学差异(8.43%,P>0.05)。结论麦默通微创旋切系统治疗乳腺良性肿瘤可缩短手术和愈合时间、减少止痛药用量和减少并发症发生,更利于患者的恢复。

Objective To explore the safety and clinical efficacy of vacuum assisted system in the treatment of benign breast tumors.Methods From January 2017 to January 2020,200 cases of breast diseasein Guangzhou Zengcheng District People′s Hospital were selected,whose everage age was(39.23±13.02)years.They were assigned to the Mammotome group(115 cases)and the open operation group(85 cases),The operative time,pain,bleeding volume,postoperative hematoma/serum swelling and infection were compared between the two groups.The patients were followed up for 6 months and 1 year after operation.Results The operative time,blood loss,recovery time and postoperative hematoma/serum swelling and infection in the Mammotome group were all lower than those in the open group.The difference was statistically significant(P<0.05).The satisfaction of the mermetone group(99.12%)was higher than that in the open group(84.34%,P<0.05).Follow-up showed that there was no significant difference between the recurrence rate(4.39%)and the open operation group(8.43%,P>0.05%).Conclusion The minimally invasive Mammotome system,compared with traditional surgery,can reduce the operation time,wound healing time,analgesic dosage and complications,which is conducived to the recovery of patients.